ADAMANTIADES-BEKET' S

DISEASE

Christos C . Zouboulis

(Advances in experimental medicine and biology ; v. 528)

History

Initial Contributions of Adamantiades and Behcet

3K. T. Calamia and E. L. Matteson

A Historical Review of Adamantiades-Behcet's Disease

7Ch. C. Zouboulis and W. Kietel

Epidemiology

Multicentre Clinical Registries

1 7P. Martus

Epidemiology of Behcet's Disease in Asian Countries and Japan

25F. Kaneko, K. Nakamura, M Sato, M. Tojo, X Zheng, and J.-Z. Zhang

Recent Epidemiological Data on Behget's Disease in Iran

3 1F. Shahram, F. Davatchi, A. Nadji, A . Jamshidi, H. Chams,C. Chams, N Shafaie, M Akbarian, and F. Gharibdoost

Prevalence of Behget's Disease among Iraqis

37Z. S. Al-Rawi and A . H. Neda

Current Epidemiological Data from the German Registry o fAdamantiades-Behcets Disease

43Ch. C. Zouboulis, I. Kötter, D. Djawari, L. Krause, U. Pleyer,R. Stadler, W. Kirch, U. Wollina, P.K. Kohl, W. Keitel,

F.R . Ochsendorf, H.P.M. Gollnick, H. Borgmann, J.R. Turnbull,R. Keitzer, E. Hölzle, E. Proksch, R . Söhnchen, H. Blech, R. Glosemeyer,G.E. Gross, Y. Hoch, E.G. Jung, G. Koch, B. Pfeiff' J. Reichrath,W. Schaffartzik, H. Weber, K Fritz, and C.E. Orfanos

Heterogenity of Clinical Manifestations in Behret's Diseaseamong Different Ethnic Groups

49A . Yelonakov, Z Alekberova, and V. Yasdovsky

Behcet's Disease in Patients of German and Turkish Origin - AComparative Study

5 3I. Kötter, R . . Vonthein, I. Günaydin, C. Müller, L. Kanz, M Zierhut,and N. Stübiger

Influence of Sex on Patients with Behcet's Disease in Korea

5 9D. Bang, S. Oh, K.-H. Lee, E.-S. Lee, and S. Lee

The Influence of Gender on the Frequency of Clinical Symptoms inBehcet's Disease

65F. Davatchi, F. Shahram, C. Chams, H. Chams, A . Nadji,A. R. Jamshidi, M Akbarian, and F. Gharibdoost

The Influence of Gender on the Severity, and the Outcome of OcularLesions in Behcet's Disease

67F. Davatchi, F. Shahram, H. Chains, A . Nadji, A. R. Jamshidi,C. Chams, M. Akbarian, and F. Gharibdoost

The Implications of Nonaphthous Beginning of Behcet's Disease

73N. Dilsen

Clinical Manifestations and Course of 200 Japanese Patients withBehcet's Disease

77C. Tanaka, T. Matsuda, E. Hayashi, Y. Imamura, and S. Ozaki

Clinical Presentation of Behcet's Disease in Internal Medicine

8 1B. Dianati, S. Saliba, G. Etienne, X Delbrel, M Grenouillet,P. Mercie, J. L. Pellegrin, M Lebras, and M. Longy-Boursier

The Change of Clinical Manifestations of Patients with Behcet' sDisease in Japan

83S. Kotake, K Namba, K Higashi, C. Goda, T. Ariga, A . Ogawa,and S. Ohno

Chronology of Clinical Manifestations in Behcet's Disease

8 5F. Shahram, K. Assadi, F. Davatchi, A . Nadji, A . Jamshidi, C. Chams,and M. Akbarian

General Aspects and Clinical Manifestations of 100 Iraqi Patient swith Behcet's Disease

9 1M. M. Al- Waiz, I. Kh. Al-Joofy, R. K. Muslih, and K M. Mousawy

The Prevalence of Behcet's Syndrome and its NeurologicalComplications in Hertfordshire, U.K .

9 5D. Kidd

Clinical and Genetic Characteristics of Late-Onset Behcet's Disease

99A. Weinberger, T. Klein, and I. Krause

Diagnostic criteria, prognostic parameters, assessment of diseas eactivity, and quality of life

The Importance of the Manifestations Besides the Ones Included i nInternational Criteria for Behcet's Disease

10 5N. Dilse n

Influence of Pathergy Test on the Accuracy of Different Diagnosi sCriteria for Behcet's Disease

109F. Davatchi, F. Shahram, A . Nadji, A . R. Jamshidi, C. Chams,H. Chams, M. Akbarian, and F. Gharibdoost

Measuring Health Related Quality of Life

11 3M. Bullinger

Univariate and Multivariate Analyses Comparing Demographic ,Genetic, Clinical, and Serological Risk Factors for Sever eAdamantiades-Behcet's Disease

12 3Ch. C. Zouboulis, J. R. Turnbull, and P. Martus

Is Long Tenn Observation of Patients with Recurrent AphthousStomatitis Necessary?

127P. Ekmekci, A. Boyvat, Özdemir, A. Giirler, and E. Gürgey

Acetylator Phenotype in Behcet's Disease

13 1R. A. Najim, K. E. Sharquie, and M H. Al-Janab i

HLA Antigen, Severity and Acetylator Phenotype in Behcet's

Disease Patients with Non-Relative Parents

139K E. Sharquie, R. A. Najim, and M. H. Al-Janabi

Risk Factors of Neuro-Behcet

143H. Houman, I. Ben Ghorbel, A. Braham-Sfaxi, M. Khanfir,M Ben Ahmed, M. Lamloum, and M. Miled

Association of HLA-B5 1 with Clinical Expression of Behcet's Disease 14 7F. Shahram, F. Davatchi, A. Nadji, A. Jamshidi, K Bahar,M. Akbarian, and F. Gharibdoos t

The Behcet's Disease Activity Index

149G. Lawton, M A . Chamberlain, B. B. Bhakta, and A . Tennant

Development of Clinical Activity Form for Korean Patients wit hBehcet's Disease

15 3E.-S. Lee, H. S. Kim, D. Bang, H. G. Yu, H Chung, D. H. Shin ,Y. W. Song, Y. B.Park, S.K.Lee, S.KShin, W.H.Kim, J.Choi,B. J. Park, and S. Lee

Living with Behcet's Disease

157G. Gilworth, M A. Chamberlain, B . Bhakta, A. Tennant,A. Silman, and D. Haskard

Pathogenesi s

Pathogenesis of Adamantiades-Behcet's disease

16 1Ch. C. Zouboulis, and T. May

Immunopathogenesis and Prevention of Uveitis with the Behcet' sDisease-Specific Peptide Linked to Cholera Toxin B

173T. Lehner, M. R. Stanford, P. A. Phipps, J. B. Sun, B. G. Xiao ,J. Holmgren, T. Shinnick, A . Hasan, and Y. Mizushima

The Role of Infectious Agents in the Pathogenesis of Behcet's Disease 18 1F. Kaneko, M. Tojo, M. Sato, and E. Isogai

Detection of Microbial DNA in Skin Lesions from Patients wit hBehcet's Disease

185M. Tojo, H. Yanagihori, X Zheng, N Oyama, E. Isogai, K Nakamura,and F. Kaneko

Association of Mycoplasma fermentans with Adamantiades-Behget's

Disease

19 1Ch. C. Zouboulis, J. R. Turnbull, and P. F. Mühlradt

Antimicrobial Activity of Synthetic Human CAP 18 Peptides t oStreptococcus sanguis Isolated from Patients with Behcet's Disease

195E. Isogai, M. Hirata, H. Isogai, K. Matuo, K. Kimura, K. Yokota,K Oguma, M. Tojo, F. Kaneko, S. Kotake, and S. Ohno

Anti-Saccharomyces Cerevisiae Antibodies

20 1I. Krause, Y. Monselise, G. Milo, and A . Weinberger

Genetics

The Human Genome Project : What We have Learnt about the MH CRegion on Chromosome 6 and its Potential to Behcet's Disease

207S. Beck

Comparison of Proteome Map Between Sera of Patients with Behcet' sDisease and Controls

21 3K.-H. Lee, Kim, S. Lee, and D. Bang

HLA Typing for Class I and Class II Antigens in Iraqi Patients wit hBehcet's Disease (Sporadic and Familial Cases)

21 7I. Kh. Al-Joofy, R. K. Muslih, K M. Mousawy, and M. M. Al-Waiz

Strong Association of MIC-A *009 of Extracellular Domains andMIC-A*A6 of Transmembrane Domain in Korean Patients withBehcet's Disease

22 1J. Mok, D. Bang, E.-S. Lee, S. Lee, and K Park

MICA Transmembrane Region Polymorphism and HLA B5 1in Tunisian Behcet's Disease Patients

225M Ben Ahmed, H. Houman, S. Abdelhak, I. Ben Ghorbel, M. Miled,K. Dellagi, and H. Louzir

HLA-B51 Frequency in Iranian Patients with Behcet's Disease

229F. Shahram, F. Davatchi, A. Nadji, N. Jamshidi, K. Bahar,M Akbarian, and C. Chams

Frequency of HLA in Patients with Behcet's Disease and Associatio nwith Occlusive Retinal Vasculitis

23 1N. A. Ermakova, Z. S. Alekberova, T. B. Prokaeva, and I. B. Poljanskaja

The ICAM1469*E is Associated with Susceptibility to OcularLesions and Vasculitis in Korean Patients with Beh9et's Disease

235E. H. Kim, J. W. Mok, D . Bang, E.-S. Lee, S. Lee, and K. S. Park

Immunolog y

Chemokines in Beh9et's Disease, a Field to Be Explored as aPotential Basis for Therapy

239M. Baggiolin i

Expression of CCR5 in Beh9et's Disease

245M Onder, N Kokturk, A . Poyraz, and M. O. Oztas

Immunophenotype and Thl/Th2 Cytokines in Patients withAdamantiades-Behcet's Disease

249K. Psarra, V. Kapsimali, G. Vaiopoulos, M Nikolopoulou ,PH. Kaklamanis, G. Palimeris, E. Kaklamani, and C. Papasteriades

Cytokine Production of Peripheral Blood Mononuclear Cell sStimulated with Streptococcus Sanguis Antigen in Patients withBeh9et's Disease

25 5K H. Lee, H. S. Kim, F Kaneko, and D. Bang

Serum Levels of Soluble TNF-a Receptor-II (P75), Circulatin gyS T-Cells and Adamantiades-Behcet's Disease Activity

26 1A. V. Elezoglou, P. P. Sfikakis, G. Vaiopoulos, V. Kapsimali, andPh. G. Kaklamanis

T-yS Receptor Restriction in Peripheral Lymphocytes of Patient swith Behget's Disease

267P. M. Van Hagen, H. Hooijkaas, M. W. M. VD Beemd, G. Verjans,and G.S. Baarsma

Lymphocyte Subsets and Activated Neutrophils in Iraqi Patient swith Behget's Disease

269K. M. Mousawy, I. Kh. Al-Joofy, R . K Muslih, and M M. Al-Waiz

L-Selectin Expression on Leukocytes of Patients with Behcet's Disease 27 3S. H. Assaad-Khalil, M. Abou-Self I. Youssef and N Farahat

Autoimmunity to S-Antigen and Retinal Vasculitis in Patients wit hBeh9et's Disease

279N A. Ermakova, Z. S. Alekberova, and T. B. Prokaeva

Nerve Growth Factor in Behcet's Disease

28 3M Accorinti, A. Bruscolini, A. Lambiase, S. Speranza, S. Bonini,and P. Pivetti-Pezz i

Low Serum Mannose-Binding Lectin Levels in Behcet's Disease

287N. Inanc, E. Birtas, S. Yavuz, T. Ergun, and H. Direskenel i

Concepts for Research

ISBD Basic Research Perspectives

293H. Direskeneli and A . Gill

Mucocutaneous manifestations

Complex Aphthosis : Evaluation for Behcet's Disease?

303M A. McCarty, and J. L. Jorizzo

Complex Aphthosis

31 1R. S. Rogers, III

Comparison of Oral Aphthae in Behcet's Disease and IdiopathicRecurrent Aphthous Stomatitis

31 7C. Chams-Davatchi, M. Shizarpour, F. Davatchi, F. Shahram ,H. Chams, A . Nadji, and A . R. Jamshidi

Bipolar Aphthosis . A Forme Fruste of Behcet's Disease

32 1A. Boyvat, P. Ekmekci, and E. Gürgey

The Effect of Smoking on the Clinical Features ofAdamantiades-Behcet's Disease

323V. G. Kaklamani, A. Tzonou, N. Markomichelakis, S. Papazoglouand Ph. G. Kaklamanis

Muco-Cutaneous Lesions of Behcet's Disease

329C. Chams-Davatchi

Dilsen's Pathergy Test in Behcet's Disease : Positive Correlationwith Clinical Manifestations

33 1K E. Sharquie, R . K. Al-Hayani, and R. A. Najim

Is Behcet's Disease a Kobner Positive Disorder?

33 3M Onder, M. Oztas, and A. Aral

Extensive Pyoderma Gangrenosum-Like Lesion in Two Cases o fBehcet's Disease, Responding only to Cyclosporin

337C. Chams-Davatchi, MShizarpour, F. Davatchi, F. Shahram,H. Chams. A . Nadji, and A . R. Jamshidi

A Case of SAPHO Syndrome with Pyoderma Gangrenosum an dInflammatory Bowel Disease Masquerading as Behcet's Disease

339O. Yamasaki, K. Iwatsuki, and F. Kaneko

Cytokine Expression Within Mucocutaneous Lesions of Behcet' sDisease : Involvement of Proinflammatory and Thl Cytokines

343M Ben Ahmed, H. Houman, I. Ben Ghorbel, A . Braham-Sfaxi,M Miled, K. Dellagi, and H. Louzir

Ocular Manifestation s

Origin and Outcome of Macular Edema in Behcet's Disease

349H. Chams, A . Lashei, A. Sadeghi-Tari, R . Karkhaneh, F. Davatchi,F. Shahram, C. Chams, and A . Abazari

Fluorescein Angiography and Optical Coherence Tomography inOcular Behcet's Disease

355L. S. Atmaca, F. Batioglu, and O. Müftüoglu

Cells of the Vitreous Body in Behcet's Disease

36 1T Ness, and L. L. Hansen

Ocular Lesions Other than Behcet's Disease in Behcet' sDisease-Affected Patients

365M Accorinti, M. P. Pirraglia, R. Corradi, M. Marino ,and P. Pivetti-Pezzi

Neurological manifestations

Neuro-Behcet's Disease (Isolated Cerebral Thrombophlebitis Excluded) 37 1A. Sbai, B. Wechsler, P. Duhaut, L . T. H. Du-Boutin, Z. Amoura,P. Cacoub, P. Godeau, and J. C. Piette

The Prevalence of Headache in Behcet's Syndrome

377

D. Kidd

Adamantiades-Behcet's Disease and Elevated Intracranial Pressurein a 12 Year Old Turkish Girl

381

U Neudorf, R. Wieland, and J. Schaper

Sensory Symptoms in Behcet's Syndrome

383M. Siepmann, and W. Kirch

Immunohistological Studies in Neuro-Behcet's Disease

385S. Hirohata, H. Arai, and T Matsumoto

Soluble Fas Ligand Levels In Cerebrospinal Fluid in Neuro-Behcet' sDisease

389E. Aoyama-Hayashi, T Matsuda, N Ohya, C. Tanaka, M. Kongozi,C. Kamo, M. Hotta, H. Ikejima, M Shiraishi, and Y. Mizushima

Cardiovascular Involvemen t

Behcet's Disease With Vascular Involvement : The Contribution o fAnticardiolipin Antibodies and Thrombomodulin

395H. Nakano, H. Oka, T Matsuda, S. Ooka, Y. Imamura, T. Suzuki,Y. Yamasaki, G . Itoh, K. Azuma, and S. Ozaki

Arterial Wall Characteristics in Patients with Adamantiades -Behcet's Disease

399A. Protogerou, J. Lekakis, K. Stamatelopoulos, K. Aznaouridis,E. Karatzis, I. Ikonomidis, Ch. Papamichael, N MarkomihelakisM. Mavrikakis, and Ph . G. Kaklamanis

The Influence of Plasma Fibrinogen and Serum Ferrum on Bloo dViscosity in Adamantiades-Behcet's Disease

405S. Mineshita, L.M. Wang, A. Miura, S. Umezu, Y. Honda,and T Sato h

Does Hyperhomocysteinemia Increase the Risk of Thrombosis i nBehcet's Disease?

41 3H. Houman, M Feki, I. B. Ghorbel, H Gadhoum, M Hsairi, S. Omar,M. Lamloum, N. Kaabachi, A. Mebazaa, and M. Miled

Pulmonary Artery Involvement in Behcet's Disease

41 9A. Akdag Köse, M Kayabali, R. Sarica, E. Saglik, and G. Azizlerli

Cardiac Manifestation in Four Patients with Adamantiades-Behcet' sDisease

423J. R. Turnbull, A . Tunsch, Y. D. Adler, L . Lehmann, H. Borgmann,and Ch.C. Zouboulis

Quantitative Evaluation of Microvessels in Behcet's Disease

427M. Pastorelli, A. L. Pasqui, L . Puccetti, U. Beermann, F. Biagi, A .Camarri, A . Palazzuoli, M. Servi, A. Costa, D. Bischeri, F. Del Santo,F. Gelli, M Saletti, F. Bruni, and A. Auter i

'8F-FDG-Positron Emission Tomography for Diagnosis of Large Vesse lArteritis in Behcet's Disease

435M Wenger, M. Baltaci, P. Klein-Weigel, E. Donnemiller, R. Moncayo,and M Schirmer

Spontaneous Platelet Aggregation in Patients with Behcet's Diseas eby Using Laser-Light Scattering Aggregometer

43 7H. Nakano, H. Oka, T. Matsuda, S. Ooka, N. Suzuki, J. Hayashi,S. Ishida, T. Suzuki, K. Hirota, and S. Ozaki

Various Clinical Manifestations

New Perspectives of Imaging Techniques for Diagnosis of OrganManifestations in Behcet's Disease

445M. Schirmer, A. Klauser, M. Wenger, M. Baltaci, and R. Moncayo

The Comparison of Ankylosing Spondylitis in Behcet's Disease andNormal Population

449A. Nadji, F. Davatchi, F. Shahram, A. Jamshidi, C. Chams,M. Akbarian, F. Gharibdoost, and K Mowla

Gastro-Intestinal Manifestations of Behcet's Disease

455W. Madanat, Z. Sharaiha, S. Khasawneh, H. Zureikat, and F. Fayyad

Gastrointestinal Disease in Behcet's Disease

459E. M. Ward, T A. Woodward, M Mazlumzadeh, and K T. Calamia

Clinical Features of Behcet's Disease Patients with Epididymitis

465D. Bang, Y -H. Cho, J. Jung, K.-H. Lee, E.-S. Lee, and S. Lee

Tonsillectomy and Behcet's Disease

47 1

M Jalessi, F. Shahram, A . Safavi, F. Davatchi, A . Nadji,A. Jamshidi, C. Chams, and F. Gharibdoost

Destructive Sinusopathy and Middle Ear Involvement in Behcet' sSyndrome

473

H. M. G. Martins, S. Santos, J. F. Lourenco, and J. A. Araüjo

Urine Abnormalities in Behcet's Disease

477F. Shahram, F. Davatchi, A. Nadji, A. Jamshidi, M Akbarian,F. Gharibdoost, and C. Chams

Treatment

Behcet's Syndrome: From Aetiology to Treatment

48 1R. J. Powell

Treatment of Ocular Manifestations of Behcet's Disease

487F. Davatch i

The Influence of the Delay of Aggressive Treatment on the Visio nand its Outcome in Behcet's Disease

493F. Davatchi, F. Shahram, H. Chams, A. Nadji, A .R. Jamshidi,C. Chams, M. Akbarian, and F. Gharibdoos t

The Clinical Outcome and Treatment in Behcet's Disease withDeep Vein Thrombosis

495A. Akdag Käse, M. Kayabali, R. Sarica, R . Kaymaz, and G.Azizlerli

The Use of Interferon-a in Behcet's Disease - Review of th eLiterature and Possible Mechanisms of Action

503I. Kötter, I. Günaydin, M. Treusch, M. Zierhut, L. Kanz, and N. Stübiger

Interferon alfa-2a in the Treatment of Ocular Adamantiades-Behcet' sDisease

51 1L. Krause, J. R. Turnbull, N. Torun, U. Pleyer, Ch. C. Zouboulis, andM. H. Foerster

Human Recombinant Interferon-a2a (rhIFNa2a) for the Treatment ofBehcet's Disease with Sight-Threatening Retinal Vasculitis

52 1I. Kötter, M. Zierhut, A. Eckstein, R. Vonthein, T. Ness, I. Günaydin ,

B. Grimbacher, S. Blaschke, H.-H. Peter, L. Kanz, and N. Stübige r

Behcet's Disease: Visual Acuity after 5 Years in Patients with alpha-Interferon Treatment

525C. M. E. Deuter, I. Kötter, I. Günaydin, M. Zierhut, and N Stübiger

Multifocal ERG Changes in Patients with Ocular Behcet's Diseas eDuring Therapy with Interferon alpha 2a

529N Stübiger, D. Besch, C. M. E. Deuter, M Zierhut, and I. Kötter

Influence of Interferon-alpha on Lymphocyte Subpopulations inBehcet's Disease

53 3M. Treusch, N. Stübiger, R . Vonthein, M. Baur, S. Koch ,I. Günaydin, L. Kanz, M. Zierhut, and I. Kötter

Interferon alpha 2a in IRPB-Derived Peptide-Induced EAU - Part I

53 7N Stübiger, I. J Crane, I. Kötter, G. R. Lamont, M. Zoeller,U. Günthert, J. V. Forrester, M. Zierhut, and R. H. Stiemer

A Case of Behcet's Disease with Pathergy Reaction at Interfero nInjection Site

54 1A. Aral, M Onder, and M. Ali Gürer

Current and Future Use of Anti-TNF Agents in the Treatment ofAutoimmune, Inflammatory Disorders

545K. T. Calamia

Successful Long-Term Treatment of Refractory Adamantiades-Behcet' sDisease (ABD) with Infliximab : Report of Two Patients

55 1C. G. Katsiari, P. G. Theodossiadis, Ph . G. Kaklamanis, N N.Markomichelakis, and P. P. Sfikakis

The Effect of Anti-Tumour Necrosis Factor Alpha (Infliximab)on Sight-Threatening Uveitis in a Patient with Behcet's Disease

557D. S. Morris, M P. Gavin, and R. D. Sturrock

Antitumor Necrosis Factor Monoclonal Antibody Therapy in a Womanwith Severe Adamantiades-Behret's Disease

56 1F. Behrens, T. Zollner, B. Moeller, J. P. Kaltwasser, R. Kaufmann,and F. R . Ochsendorf

Efficacy of Corticosteroids and Cyclosporin in the Treatment o fRetinal Vasculitis in Patients with Behcet's Disease

563N A. Ermakova

Enhancement of Transmucosal Permeation of Cyclosporine byBenzalkonium Chloride

567P. Van Der Bijl, A. D. Van Eyk, A. A. Gareis, and I. O. C. Thompso n

Azathioprine and Low Dose Pulse Cyclophospha-Mide in Sever eOcular Lesions of Behcet's Disease

57 1

F. Shahram, F. Davatchi, H. Chams, A . Nadji, A . Jamshidi,M. Akbarian, and F. Gharibdoost

Low Dose MTX for Progressive Neuro-Behcet's Disease

575H. Kikuchi, K. Aramaki, and S. Hirohata

High Dose Methotrexate for Ocular Lesions of Behcet's Disease

579F. Davatchi, F. Shahram, H. Chams, A . R. Jamshidi, A. Nadji,C. Chams, M Akbarian, and F. Gharibdoost

Therapeutic Effect of Thalidomide through Cytokine and Chemokin eRegulation in Herpes Simplex Virus-Induced Behcet's Disease-LikeAnimal Model

585S. Sohn, E.-S. Lee, S. I. Lee, Y. A . Kim, H. J. Kwon, D. Bang, and S. Lee

Pentoxifylline Use for Behcet's Disease

59 1G. C. Liang, and E. M. Chang

Cataract Surgery in Behcet's Disease Patients

595N. A. Ermakova, and E. A. Egoro v

Do Metal Surgical Staples Induce Post-Surgical Intestinal Ulcer i nBehcet's Disease?

599T. Matsuda, Y. Imamura, A. Shimizu, E. Hayashi, S. Tsukikawa,M. Enomoto, and T. Nakagawa

Patient - Physician Relationshi p

Clinicans, Scientists and Patients

603C. G. Barnes

Hopes of Patients with Behcet's Disease in Japan toward sResearchers and the Relationship between Patients and Medica lStaff Concerning Social Work

605T. Nishida, M. Nishida, M. Wakayama, M. Nishida, and S. Ohno

Jordan Friends of Behcet's Disease Patients Society

609J. Tamimi, and W. Madanat

The Relationship between Patient Groups and Physicians from aUK Support Group Perspective

61 3G. Seaman, and R. Pearce

"Living With Behcet" - A Young Patients' Group

61 9A . Müller

Private Practice Offices Serve as Centers for Adamantiades-Behret' sDisease

62 1K Fritz

The Editor

627

Index

629